Company Filing History:
2 out of 100 
2 out of 159 Years Active: 2017-2018
Title: Haowei Wang: Innovator in Androgen Receptor-Mediated Treatments
Introduction
Haowei Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the treatment of androgen receptor-mediated disorders. With a total of 2 patents, his work focuses on innovative methods that have the potential to impact the treatment of serious diseases.
Latest Patents
Wang's latest patents include groundbreaking methods for treating androgen receptor-mediated diseases, such as breast cancer, using imidazoline derivatives. These patents describe the preparation methods of these derivatives and their applications in medicine. Additionally, he has developed new imidazoline derivatives that are represented by specific formulas, detailing their preparation methods, pharmaceutical compositions, and applications in creating androgen receptor antagonists and medicaments for treating diseases like prostate cancer.
Career Highlights
Throughout his career, Haowei Wang has worked with notable companies in the pharmaceutical industry, including Shanghai Hengrui Pharmaceutical Co., Ltd. and Jiangsu Hengrui Medicine Company Ltd. His experience in these organizations has allowed him to contribute to significant advancements in medical treatments.
Collaborations
Wang has collaborated with esteemed colleagues, including Hejun Lu and Piaoyang Sun. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.
Conclusion
Haowei Wang's contributions to the field of medicine through his patents and collaborations highlight his role as an influential inventor. His work in developing treatments for androgen receptor-mediated disorders showcases the potential for innovative solutions in healthcare.